Theohari and colleagues investigated the expression of Smad7 in 150 invasive breast carcinoma specimens and showed that Smad7 levels positively correlate with tumor size, stage, matrix metalloproteinase (MMP)-9 and MMP-14 expression thus resulting in an aggressive phenotype [56]. The gene discussed is SMAD7; the disease is invasive breast carcinoma.